Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $8.1700 (-6.84%) ($8.1700 - $8.1700) on Wed. Jan. 27, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.62% (three month average) | RSI | 39 | Latest Price | $8.1700(-6.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -1.6% a day on average for past five trading days. | Weekly Trend | AUTL declines -2.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) LIT(13%) SKYY(13%) XBI(13%) BNDX(12%) IBB(12%) | Factors Impacting AUTL price | AUTL will decline at least -2.31% in a week (0% probabilities). TBT(-8%) USO(-7%) VIXM(-6%) IGOV(-6%) UNG(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.31% (StdDev 4.62%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $2.76(-66.22%) | Inflection Point | Yes | Resistance Level | $8.89 | 5 Day Moving Average | $8.6(-5%) | 10 Day Moving Average | $8.76(-6.74%) | 20 Day Moving Average | $8.89(-8.1%) | To recent high | -31.9% | To recent low | 0.1% | Market Cap | $427m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |